In addition to the DTA Fibrosis Score, VIDA’s ILD offering enables the following trial services: • Enhanced eligibility assessments, supported by novel, patented visualizations, including Tomographic ...

• Robust, comprehensive endpoint assessments, with up to 15,000 metrics per scan utilizing CT and Xenon MRI biomarkers to measure changes in lung structure and function. VIDA’s platform supports ...